PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

where are we at at the moment ?, page-37

  1. 337 Posts.
    lightbulb Created with Sketch. 93
    Keep whispering these sweet nothings to me lads!

    Glass half full.

    Point of maximum confusion, pessimism subsiding………. something might be brewing in the background??

    Maximum upside, as we start to focus on our Phase 3 stage 2 trial with (hopefully) our optimum dose and our impeccable safety profile, therapeutic duration and then our total addressable market with our rock solid supplier.

    Someone might have to check the beechwood forest is healthy?

    Hutz, give me a “go PAR”
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.